Fischer Medical Ventures through its Wholly owned Subsidiary - Time Medical International Ventures (India) announced the successful partnering with Singapore-based innovators Nervotec to enable Blood Pressure, Hemoglobin and HbA1C screening through camera-enabled device. This collaboration marks a significant stride towards revolutionizing healthcare screening through advanced, contactless video-based vital signs monitoring technology.

Nervotec is a Singapore-based company that empowers predictive healthcare via its contactless solution without wearables. Nervotec's innovative solution uses remote photoplethysmography (rPPG) technology and artificial intelligence to measure physiological biomarkers such as heart rate, heart rate variability, respiration rate, oxygen saturation, stress scores and even blood pressure just from a person's face using any camera-enabled device like smartphone, laptop, or tablet. Users simply had to look at their camera-enabled device and within minutes, Nervotec's algorithms will analyze his/her vitals, making wearables or invasive procedures redundant. Clinically validated in Singapore, Nervotec's process is fast, accurate, and cost effective, a ground-breaking solution to enable large scale screening for early detection and intervention.